ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 45 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,088,000 | -58.8% | 7,114,000 | -57.2% | 0.11% | -59.3% |
| Q1 2019 | $14,762,000 | +36.4% | 16,632,000 | +27.9% | 0.28% | +182.8% |
| Q4 2018 | $10,820,000 | +112.4% | 13,000,000 | +116.7% | 0.10% | +43.5% |
| Q3 2018 | $5,094,000 | -65.6% | 6,000,000 | -60.6% | 0.07% | -66.7% |
| Q2 2018 | $14,796,000 | +24.7% | 15,230,000 | +17.3% | 0.21% | +10.1% |
| Q1 2018 | $11,866,000 | +1.0% | 12,985,000 | -5.8% | 0.19% | +2.2% |
| Q4 2017 | $11,743,000 | -17.2% | 13,785,000 | -12.1% | 0.18% | -13.2% |
| Q3 2017 | $14,176,000 | +135.4% | 15,690,000 | +124.1% | 0.21% | +116.3% |
| Q2 2017 | $6,021,000 | -81.2% | 7,000,000 | -81.3% | 0.10% | -78.9% |
| Q1 2017 | $31,980,000 | -24.9% | 37,450,000 | +1.5% | 0.46% | -17.3% |
| Q4 2015 | $42,596,000 | – | 36,900,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
| Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
| Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
| Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
| Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
| SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
| Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |